MedPath

Effect of remote ischemic conditioning on pain-free walking distance and angiogenesis in patients with chronic arterial occlusive disease.

Phase 1
Recruiting
Conditions
I70.29
Registration Number
DRKS00025735
Lead Sponsor
niversitätsklinikum Schleswig-Holstein Campus Kiel
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

paVk stage IIb;
- written informed consent

Exclusion Criteria

- Age <18 years; >75 years
- Current participation in another clinical intervention study
- Participation in another clinical intervention study within the last 30 days
-Cognitive/language barriers, comprehension problems during the educational process
- Severe renal and hepatic insufficiency
- Severe COPD (FeV1= 50%).
- Existing drug and alcohol abuse
- Neurological diseases (Parkinson's disease, multiple sclerosis, epilepsy, Alzheimer's disease)
- Acute infections
- Diabetes mellitus
- Pronounced pAVK of the upper extremities
- Polyneuropathy of the upper extremities
- Arterio-venous fistula (shunt) or lymphedema of the upper extremities
- Myocardial infarction < 2 months
- Stroke < 2 months
- Malignancy
- Pregnancy
- Lack of compliance, >3 missed RIC applications.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain-free and total walking distance determined using the standardized treadmill test
Secondary Outcome Measures
NameTimeMethod
(1)Does RIC lead to improved microcirculation of the affected extremities (measured by thermal imaging camera)?<br>(2)Does RIC lead to an improvement in quality of life (SF-36 quality of life questionnaire)?<br>(3)What is the impact of RIC on renal function?<br>(4)Does long-term RIC change the activity of atherosclerotic inflammatory response (Il-1,Il-6, hs-CRP, fibrinogen)?<br>(5)Do molecular and protein biochemical changes in serum and tissue samples occur as a result of RIC? <br>(6)Does RIC increase the number of endothelial progenitor cells in the blood.<br><br>Translated with www.DeepL.com/Translator (free version)
© Copyright 2025. All Rights Reserved by MedPath